Loar Holdings (LOAR) Q3 2026 Earnings Call Transcript
Source: The Motley Fool
Loar Holdings reported Q3 2026 revenue of $176.2 million, up 39.0% year over year, and adjusted EBITDA of $71.9 million, up 46.5%; adjusted EBITDA margin expanded to 40.8% from 38.7%. The company raised 2026 revenue guidance to $669 million-$679 million and adjusted EPS guidance to $1.36-$1.40, and initiated 2027 guidance for revenue of $745 million-$755 million and adjusted EBITDA of $312 million-$317 million, at an approximately 42% margin. Growth and record backlog were supported by a book-to-bill ratio above 1.1, while management cited choppy defense sales timing and airlines managing capacity amid sustained high oil prices as risks.
Analysis
The key underwriting question is not demand visibility but how much of the promised growth converts to durable cash earnings. New OE wins can secure platform content for years, but qualification, ramp execution and customer production schedules create a lag between backlog and cash; rising investment needs make conversion more important than headline book-to-bill. Management’s claim that new wins are starting above expected margins is encouraging, but needs verification in reported segment economics over the next few quarters.
There is also a meaningful gap between operating momentum and equity-level earnings power: acquisition amortization depresses GAAP results, while interest expense is a real cash claim. Strong recent cash conversion may be timing-sensitive; verify working-capital movements, leverage and interest coverage in filings before paying a premium for the “cash compounder” narrative. Incremental aircraft production benefits qualified component suppliers, but airline capacity restraint from fuel costs is a check on aftermarket volume; LOAR’s content and pricing may cushion that exposure, not eliminate it.
Near term, raised guidance and initial 2027 visibility support sentiment, though valuation and consensus expectations are unavailable, so the magnitude of upside surprise cannot be assessed. Over 1–3 months, monitor backlog conversion, OE shipment cadence and cash generation. Over 6–18 months, the thesis depends on margin expansion surviving acquisition integration and higher capex. Contrarian risk: the market may over-credit management’s confidence in proprietary wins while underweighting financing costs and lumpy M&A; conversely, GAAP EPS weakness may obscure genuine operating improvement.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.55
Ticker Sentiment
Key Decisions for Investors
- Do not chase the post-call strength without checking valuation and net debt: those are essential missing inputs. Consider a staged long only on a pullback if organic growth remains healthy and the margin trajectory is intact; size against financing and execution risk.
- Treat the 2027 margin target as a testable catalyst, not a given. Reassess after the next one or two reports for evidence that new-business ramps and productivity lift operating margins without deteriorating cash conversion.
- Watch items: backlog-to-revenue conversion, working-capital contribution to free cash flow, capex versus plan, acquisition cadence/price, and interest coverage. Verify these against SEC filings; the transcript’s adjusted metrics alone do not establish balance-sheet resilience.
- Falsify the constructive thesis if guidance is cut, organic growth or order momentum materially weakens, margins stall below the stated path, or cash conversion fades while debt-service costs remain elevated. No options trade is warranted without valuation and implied-volatility context.
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Iran says tankers struck in Hormuz amid fears of new US attack
- The Iran war has cost U.S. households nearly $2,000 each. New strikes could keep the bill climbing
- Shield AI To Hit $28.8 Billion Value With $5.3 Billion Radar Acquisition
- We're raising our price target on Cardinal Health after another stellar quarter of profits